Arbital Health Secures $31M Series B Funding Round Led by Valtruis

Arbital Health, a healthcare technology company, has announced a $31M Series B funding round led by Valtruis, with existing investors Transformation Capital, Shaper Capital, and Healthy Ventures also participating. The investment aims to enhance Arbital Health's payer and provider capabilities, accelerate value-based care contract performance monitoring, and expand its AI-powered platform.

The funds will be utilized to grow the company's actuarial team and further develop its platform, which aids providers and payers in delivering improved patient outcomes and sustainable financial performance. Managing Director at Valtruis, Mike Spadafore, expressed support for Arbital Health, emphasizing the critical infrastructure it offers to empower payers and providers in reconciling risk-based contracts.

Arbital Health has grown its client roster to include over 40 payers, providers, and value-based care enablers, in addition to onboarding more than 600,000 patient lives to its platform. Co-Founder, President, and CEO of Arbital Health, Brian Overstreet, highlighted the complexity within healthcare organizations in aligning financial results with improved patient outcomes, indicating Arbital Health's mission to tackle this challenge. The company provides the necessary infrastructure for managing risk-based contracts, with a focus on improving patient outcomes and financial performance.